2015年2月25日
In today’s global economy, companies large and small create content at an ever-increasing rate in an effort to be noticed, but with that comes the challenge of harnessing all they make to engage their audiences. At the upcoming Content Management Strategies/DITA North America conference in April, CSOFT International will share its secrets for how to develop content management strategies with global audiences in mind.
Daniel Herron, a content strategist at CSOFT who will be speaking at the event, said, “We always begin by asking our clients what they want to achieve globally, and then we work backwards from there to design the best content management strategies to help them achieve that goal.”
Herron will be joined by speaker Marisa Chavarria, a specialist with DITA process and methodologies at CSOFT, at a session titled “No Puns Allowed: Writing and Managing Content for Your Global Audience” on Monday, April 20th.
The CMS/DITA North America conference will be held in Chicago, Illinois, from April 20-22. This year’s event will feature more than 75 presentations, with each exhibitor sharing techniques that help content creators and managers produce attractive, effective publications and ensure the quality of deliveries to customers.
Click here to visit the CIDM official site.
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com
